The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3078964 15 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The purpose of the present study is to examine the diagnostic and predictive accuracy of the thyroglobulin (Tg) to thyroid stimulating hormone (TSH) and TSH/Tg ratios in normothyroid patients with differentiated thyroid cancer (DTC). We conducted a retrospective cohort study evaluating the diagnostic accuracy of the serum Tg/TSH and TSH/Tg ratios in normothyroid patients with thyroid nodules. We also systematically searched the international literature using the Medline, Cochrane's CENTRAL, Scopus, Clinicaltrials.gov, EMBASE, and Google Scholar databases for evidence concerning the diagnostic and predictive accuracy of these ratios. Overall, 374 patients were identified in our cohort study of whom 240 were treated for benign disease and 134 were treated for DTC. Significant differences were noted in the Tg/TSH and TSH/Tg values among cases with malignant and benign disease (P=0.020). However, the diagnostic ROC curve did not confirm these results (Tg/TSH=0.572 and TSH/Tg=0.428). After searching the international literature, we identified 8 studies. The majority of the included data reported significant differences among patients with benign/malignant disease and those with successful iodine therapy compared to those with disease relapse. However, the clinical relevance was clearer among studies that investigated the usefulness of these ratios in predicting recurrent disease. The findings of our study support that the Tg/TSH ratio increases in patients with DTC and can, thus, become useful in the future as a predictive marker of ablative 131I therapy success. However, given the significant variability of Tg its diagnostic accuracy remains to date minimal; thus, the actual cut-off value that can be used to discriminate cancer cases from benign disease has not been determined yet. © Copyright: the Author(s), 2020
Έτος δημοσίευσης:
2020
Συγγραφείς:
Karvounis, E.
Kappas, I.
Angelousi, A.
Makris, G.-M.
Siamatras, T.D.
Kassi, E.
Περιοδικό:
Oncology Reviews
Εκδότης:
Page Press Publications
Τόμος:
14
Αριθμός / τεύχος:
2
Σελίδες:
152-157
Λέξεις-κλειδιά:
iodine 131; thyroglobulin; thyrotropin, ablation therapy; adult; aged; cohort analysis; comparative study; diagnostic accuracy; diagnostic test accuracy study; differentiated thyroid cancer; evaluation study; female; human; male; meta analysis; outcome assessment; practice guideline; predictive value; priority journal; receiver operating characteristic; retrospective study; Review; sex difference; systematic review; thyroid nodule; treatment outcome
Επίσημο URL (Εκδότης):
DOI:
10.4081/oncol.2020.439
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.